Oxford Immunotec Bulks Up Immunology Dx Offering
Executive Summary
Oxford Immunotec, an immunology-focused diagnostics company, has acquired US company Immunetics.
You may also be interested in...
Oxford Immunotec Edges Closer To Transplant Product Launch
Oxford Immunotec has set its sights on a 2017 launch for two new immune-response tests emerging from its T-spot platform, on the back of interim results from a major clinical study due at the end of Q1.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Angle Files De Novo Submission For Parsortix System In Breast Cancer
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.